Celcuity (CELC) Change in Account Payables (2016 - 2025)
Celcuity's (CELC) quarterly Change in Account Payables came in at -$4.8 million in Q4 2025, down 2273.42% YoY from $222000.0 in Q4 2024, and down 8672.73% on a QoQ basis from -$55000.0 in Q3 2025.
Celcuity (CELC) Change in Account Payables (2016 - 2025) Analysis & Trends
Celcuity (CELC) has 10 years of Change in Account Payables data on file, last reported at -$4.8 million in Q4 2025.
- Quarterly Change in Account Payables fell 2273.42% year-over-year to -$4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.0 million (down 170.44% YoY) and the FY2025 annual result came in at -$3.0 million, down 170.44% from the prior year.
- Change in Account Payables slipped to -$4.8 million in Q4 2025, from -$55000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.9 million in Q3 2024 to a low of -$4.8 million in Q4 2025.
- A 5-year average of $304481.3 and a median of $301047.0 in 2021 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2021 — Change in Account Payables jumped 19904.03% — and 2025, when it plunged 2273.42%.
- Tracing CELC's Change in Account Payables over 5 years: stood at -$247449.0 in 2021, then plunged by 92.4% to -$476096.0 in 2022, then fell by 26.3% to -$601309.0 in 2023, then soared by 136.92% to $222000.0 in 2024, then sank by 2273.42% to -$4.8 million in 2025.
- The last three Change in Account Payables figures came in at -$4.8 million (Q4 2025), -$55000.0 (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Celcuity | 4.50 Bn | 4.50 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.83 Mn |
| Dec 31, 2025 | -4.83 Mn |
| Sep 30, 2025 | -55,000.00 |
| Sep 30, 2025 | -55,000.00 |
| Jun 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 613,000.00 |
| Mar 31, 2025 | 613,000.00 |
| Dec 31, 2024 | 222,000.00 |
| Dec 31, 2024 | 222,000.00 |
| Sep 30, 2024 | 2.91 Mn |
| Sep 30, 2024 | 2.91 Mn |
| Jun 30, 2024 | 945,000.00 |
| Jun 30, 2024 | 945,000.00 |
| Mar 31, 2024 | 238,000.00 |
| Mar 31, 2024 | 238,000.00 |
| Dec 31, 2023 | -601,309.00 |
| Dec 31, 2023 | -601,309.00 |
| Sep 30, 2023 | 2.61 Mn |
| Sep 30, 2023 | 2.61 Mn |